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SCA7 Knockin Mice Model Human SCA7 and Reveal
Gradual Accumulation of Mutant Ataxin-7 in Neurons
and Abnormalities in Short-Term Plasticity
other polyglutaminopathies, however, SCA7 patients
suffer from cone-rod dystrophy, which presents initially
as loss of color discrimination in tritan axis (blue-yellow)
followed by progressive pigmentary macular degenera-
tion and loss of visual acuity, eventually leading to blind-
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ease, which is characterized by more rapid progression6 Howard Hughes Medical Institute
and a broader spectrum of phenotypes than adult-onsetBaylor College of Medicine
disease. It is worthy of note that the SCA7 protein,Houston, Texas 77030
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becomes sufficiently long does it cause more wide-
spread damage.
Several groups have generated SCA7 transgenic miceSummary
using heterologous promoters (Yvert et al., 2000, 2001;
La Spada et al., 2001). Yvert et al. (2002) generated twoWe targeted 266 CAG repeats (a number that causes
models expressing SCA7 cDNA with 90 CAG repeats ininfantile-onset disease) into the mouse Sca7 locus to
either cerebellar Purkinje cells or rod photoreceptors.generate an authentic model of spinocerebellar ataxia
Both models showed degeneration of cell types thattype 7 (SCA7). These mice reproduced features of in-
overexpress the transgene, and the authors also re-fantile SCA7 (ataxia, visual impairments, and prema-
ported that mutant ataxin-7 is truncated to form anture death) and showed impaired short-term synaptic
amino-terminal fragment (Yvert et al., 2000). More re-potentiation; downregulation of photoreceptor-spe-
cently, the same group produced another two lines ofcific genes, despite apparently normal CRX activity,
mice expressing 10 or 128 CAG repeats in neurons usingled to shortening of photoreceptor outer segments.
platelet-derived growth factor chain B promoter (YvertWild-type ataxin-7 was barely detectable, as was mu-
et al., 2001). The mRNA levels of the transgene are thetant ataxin-7 in young animals; with increasing age,
same in both of these lines, but they could detect nohowever, ataxin-7 staining became more pronounced.
wild-type ataxin-7, which suggests that this protein isNeurons that appeared most vulnerable had relatively
rapidly degraded (Yvert et al., 2001). La Spada et al.high levels of mutant ataxin-7; it is interesting, however,
(2001) generated SCA7 mice expressing 92 CAG repeatsthat marked dysfunction occurred in these neurons
using the murine prion protein promoter; these miceweeks prior to the appearance of nuclear inclusions.
have retinal (La Spada et al., 2001) and cerebellar degen-These data demonstrate that glutamine expansion sta-
eration (Garden et al., 2002). This group found that cone-bilizes mutant ataxin-7, provide an explanation for se-
rod homeobox protein (CRX) interacts with ataxin-7 andlective neuronal vulnerability, and show that mutant
suggested that CRX dysfunction is responsible for cone-
ataxin-7 impairs posttetanic potentiation (PTP).
rod dystrophy in SCA7 (La Spada et al., 2001). Although
these studies nicely demonstrated that retinal and Pur-
Introduction kinje cells are vulnerable to ataxin-7 toxicity in mice,
there are important aspects of SCA7 pathogenesis that
SCA7 is one of a growing number of autosomal dominant cannot be addressed with transgenic mouse models.
neurodegenerative diseases caused by the expansion Because heterologous promoters are used, transgenics
of a translated CAG repeat. This repeat produces an cannot authentically reproduce the selective neuronal
abnormally long polyglutamine (Q) tract in the respective vulnerability that typifies SCA7. It is also difficult to de-
proteins and confers a toxic gain-of-function. Numbered termine whether the pathogenic events in these mice
among the nine polyglutamine diseases that have been parallel those occurring in humans, or whether they
identified so far are Huntington’s disease and several might be in part due to transgene overexpression.
of the spinocerebellar ataxias (SCAs) (Zoghbi and Orr, We wished to create a knockin mouse model that
2000; Nakamura et al., 2001). Like other SCAs, SCA7 would express ataxin-7 at endogenous levels in the
causes progressive loss of motor coordination (ataxia), proper spatio-temporal pattern so that we could better
speech impairment (dysarthria), and swallowing difficul- address such open questions as selective neuronal vul-
ties (dysphagia), with longer CAG tracts producing more nerability and the series of pathogenic events causing
severe and rapid disease course. In distinction from the disease progression. The challenge with polyglutamine
diseases is that the short life span of the mouse is lim-
iting; prolonged exposure to the mutant protein is nor-*Correspondence: hzoghbi@bcm.tmc.edu
Neuron
384
mally necessary for neurons to develop dysfunction. Table 1. Comparison between an Infantile SCA7 Patient
There are two exceptions to this requirement, however: and Sca7266Q/5Q Mice
overexpression of the mutant (or even the wild-type)
Symptoms Infantile SCA7 Patient Sca7266Q/5Q Mice
protein at high enough levels will produce neurodegen-
Age of onset 1 month 5 weekseration, as will extremely long CAG tracts (Fernandez-
Weight loss  Funez et al., 2000; Gusella and MacDonald, 2000; Lin
Ptosis  et al., 2001; Zoghbi and Botas, 2002). We were recently
Visual impairment  
successful in generating a knockin mouse model of Ataxia  
SCA1, another polyglutamine disease, using a very long Muscle wasting  
Kyphosis  polyglutamine tract (154 CAGs) (Watase et al., 2002),
Tremors  but the fact that this repeat size has never been ob-
Death 6 months 4–5 monthsserved in a human SCA1 patient precluded direct com-
parisons between mouse and human. In the case of Symptoms of an infantile SCA7 patient are compared with those of
Sca7266Q/5Q mice. This patient is an individual IV-2 from BASCA kin-SCA7, on the other hand, extremely long repeats do
dred (Benton et al., 1998), and expanded CAG repeats from thisoccur (there are infantile SCA7 cases with 200–460 CAG
patient were used to construct a targeting vector (see Experimentalrepeats [Benton et al., 1998; Johansson et al., 1998; van
Procedures). marks each symptom manifested in patient and
de Warrenburg et al., 2001]), and this presented a unique Sca7266Q/5Q mice.
opportunity. We reasoned that targeting a repeat in this
size range would produce a mouse model that could be
that the mutant protein may exist in an insoluble formevaluated in direct comparison to infantile SCA7. To this
or in complexes with other proteins.end, we introduced 266 CAG repeats into the mouse
Sca7 locus (Sca7266Q/5Q mice).
General Features of Sca7266Q/5Q MiceHere we report the full characterization of Sca7266Q/5Q
We generated two independent lines of Sca7266Q/5Q micemice and show that these mice did indeed reproduce the
(lines C1 and H10). Both lines were indistinguishablesalient features of infantile SCA7. These mice allowed us
from wild-type littermates by visual observation until 5to probe important aspects of SCA7 pathogenesis such
weeks of age, at which time they started to developas selective neuronal vulnerability and the functional
features of infantile SCA7 patients, such as progressiveconsequences of the mutant protein on the retina, cere-
weight loss, droopy eyelids (ptosis), ataxia, musclebellum, and hippocampus without the confounding
wasting, curvature of the spine (kyphosis), and tremorseffects of overexpression. Lastly, certain intriguing dif-
(Table 1; Figure 1D). CAG repeat size in these two linesferences between the knockin mice and previous trans-
of Sca7266Q/5Q mice was relatively stable, occasionallygenic models shed light on the strengths and limitations
showing less than ten CAG repeat (30 nucleotides) con-of each.
traction, which did not change the progression or sever-
ity of the disease. Sca7266Q/5Q mice showed a similarResults
weight gain pattern as wild-type mice up to 5 weeks
but gained little if any weight afterward (Figure 1E). At
Generation of Sca7266Q/5Q Mice
the terminal stage of the disease, animals became ex-
Mouse Sca7 is highly homologous to human SCA7, with tremely hypokinetic and did not drink nor eat, even when
the peptide sequence showing 88.7% identity (Stro¨m et their chow was wetted and placed at the bottom of the
al., 2002). Whereas the CAG repeat tract in human SCA7 cage. Sca7266Q/5Q mice died around 14–19 weeks of age.
is polymorphic (ten repeats are the most common), Male Sca7266Q/5Q mice had reduced fertility after 13
mouse Sca7 has only five CAG repeats in the corre- weeks of age. Female Sca7266Q/5Q mice, on the other hand,
sponding region. We introduced 266 CAG repeats into failed to deliver pups when they were mated after 8
the mouse Sca7 locus using homologous recombination weeks of age. Some Sca7266Q/5Q mice developed myo-
in embryonic stem (ES) cells (Figure 1A and see Experi- clonic seizures around 12 weeks of age. Homozygous
mental Procedures). Germline transmission of a targeted mice (Sca7266Q/266Q mice) showed a gene dosage effect,
allele was confirmed by Southern analysis (Figure 1B) with their phenotype being more severe and disease
and PCR amplification of CAG repeats (data not shown). progression more rapid, resulting in death around 7–8
Both mouse and human ataxin-7 have a nuclear local- weeks of age. The enhanced toxicity in the homozygous
ization signal (NLS) (David et al., 1997; Stro¨m et al., mice is most likely due to higher levels of expanded
2002). In order to determine the subcellular localization ataxin-7 (gain-of-function) rather than partial deficiency
of ataxin-7 in mouse cerebellum, we isolated the nuclear of wild-type ataxin-7’s function: mice compound hetero-
and cytoplasmic fractions and analyzed them by West- zygotes for expanded and a loss-of-function Sca7 al-
ern blotting (Figure 1C). Wild-type ataxin-7 was detected leles (Sca7266Q/ mice) do not show enhanced toxicity as
as 93 kDa protein in the nuclear extracts, but not in the those homozygotes for the expanded allele (S.-Y.Y. and
cytoplasmic extracts of wild-type or Sca7266Q/5Q mice, H.Y.Z, unpublished data). Because Sca7266Q/266Q mice
showing that it is predominantly a nuclear protein in the were so severely affected and because both knockin
cerebellum (Figure 1C). Mutant ataxin-7 is predicted to lines showed similar phenotypes, only Sca7266Q/5Q mice
migrate at 190 kDa, given the size of expanded poly- (line H10) were used for subsequent characterization.
glutamine tract, but no immunoreactivity in this size
range was detected in Sca7266Q/5Q lanes. Ataxin-7 immu- Cone-Rod Dystrophy in Sca7266Q/5Q Mice
noreactivity was detected in the stacking gel of the Sca7266Q/5Q mice were born with normal eyes, but as they
aged, the eyes receded and ptosis developed. In orderSca7266Q/5Q nuclear extract lane (Figure 1C), suggesting
Pathogenic Effects of Mutant Ataxin-7 in SCA7 Mice
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to determine whether this was accompanied by a pro- functional difference between S and M cones, we filtered
the light using band pass filters specific for the twogressive decline of retinal function, we evaluated elec-
troretinograms (ERGs) of wild-type and Sca7266Q/5Q mice classes of cones and measured the response (Figures
2Q–2T and 2U–2X). At 5 weeks, wild-type and Sca7266Q/5Qat three different ages: 5, 9, and 14 weeks. The ERGs
of wild-type mice from these age groups were not signifi- mice showed little difference when stimulated with white
or UV light, but stimulation with green light revealed acantly different, so we pooled the data for all wild-type
animals. We measured scotopic b-waves, a-waves, and statistically significant decrease (p  0.039) (Table 2;
Figure 2V). The cone response continued to decreasecone-driven b-waves (Table 2; Figure 2)
The scotopic (dark-adapted) b-wave is an extracellu- at 9 weeks, and by 14 weeks, it was undetectable (Fig-
ures 2P, 2T, and 2X). The trend toward a decline at 5lar field potential that arises primarily from ON-rod bi-
polar cells in response to dim flashes of light (Pugh et weeks and the significant decline at 9 weeks of cone
ERGs suggests that cone dysfunction occurs prior toal., 1998). The relationship between scotopic b-wave
amplitude and intensity can be modeled using a hyper- rod dysfunction in Sca7266Q/5Q mice.
The abnormal ERG results prompted us to look atbolic saturation function (see Experimental Procedures).
This model yields two parameters, bmax,scot and I0.5, repre- the expression levels of several photoreceptor-specific
genes in the eyes of Sca7266Q/5Q mice (Figure 3A). Wesenting the maximum b-wave amplitude and the inten-
sity that provides half saturation, respectively. At 5 decided to look at the expression levels of three pho-
topigment genes (blue cone opsin [Bcp], green coneweeks of age, scotopic b-waves from Sca7266Q/5Q mice
were indistinguishable from their wild-type counter- opsin [Gcp], and rhodopsin [Rho]), rod transducin
(Gnat1), and rhodopsin kinase (Rhok). Bcp (S opsin) andparts. However, as they aged, Sca7266Q/5Q mice demon-
strated both a decline in bmax,scot and an increase in I0.5 Gcp (M opsin) are cone-specific markers, whereas Rho
and Gnat1 are rod-specific markers. Rhok is present in(Table 2). At 9 weeks, rod-driven function had decreased
to 65% compared to wild-type. By 14 weeks, bmax,scot had both cones and rods (Lyubarsky et al., 2000). Expression
of all these genes showed a progressive decrease withdecreased to 25% of wild-type (Figures 2A–2D). It was
not possible to study the mutant mice beyond 15 weeks age. Cone-specific markers showed about 60% reduc-
tion in a presymptomatic 4-week-old mutant (Figure 3A).because of their frailty. Our data suggest that the rod
system of Sca7266Q/5Q mice develops properly and is ca- The youngest mice that were tested on ERGs were 5
weeks old when they began to show some decrease inpable of normal phototransduction. The decrease in the
scotopic b-wave may have resulted from a defect in cone activity (Table 2; Figure 2). It is interesting to note
that the cone photoreceptors remained functional eventhe rod bipolar cells, from decreased input of the rod
photoreceptors, or both. with more than 60% decrease of both cone-specific
photopigments. Rod-specific markers were downregu-To examine rod photoreceptor function, we analyzed
the ERG a-wave, which arises almost exclusively from lated later than cone-specific markers. This may explain
why cone dysfunction appeared earlier than rod dys-the rod photoreceptors in mouse (Pugh et al., 1998). An
intense flash was used to measure the saturated a-wave function in ERG studies.
Hematoxylin and eosin staining of Sca7266Q/5Q retinasamplitude, amax (Figures 2E–2H). At 5 weeks of age, there
was no significant difference between the wild-type and revealed progressive shortening of outer segments and
thinning of inner plexiform layer (IPL) (Figure 3B). Al-Sca7266Q/5Q mice. Sca7266Q/5Q mice showed a steady de-
cline in saturated a-wave amplitude with age: at 9 weeks, though endogenous levels of ataxin-7 were very low in
wild-type retina, mutant ataxin-7 accumulated inamax had declined to 60%, and by 14 weeks, amax was
decreased to 30% of normal. To analyze the amplifica- Sca7266Q/5Q retina, forming microaggregates around 8
weeks of age (Table 3)—and single, large nuclear inclu-tion of the rod transduction cascade, a series of a-waves
were fitted to Equation 1 (see Experimental Procedures) sions (NIs) around 10 weeks (Figures 3C and 4A)—when
retinal dysfunction has already set in. Mutant ataxin-7(Lamb and Pugh, 1992), and the parameter kA was de-
rived (Figures 2I–2L). There was no statistically signifi- accumulation was observed throughout the retina, but
it occurred more rapidly in outer nuclear layer (ONL)cant difference in the amplification parameter kA be-
tween wild-type and Sca7266Q/5Q mice at any of the ages (specifically the top layer of ONL) and inner nuclear layer
(INL) than in ganglion cell layer (GCL) (Figures 3C andtested (Table 2). The amplitude of the a-wave is directly
proportional to the number of cyclic nucleotide-gated 4A). In mature mouse retina, the nuclei of cones are
aligned directly beneath the inner segments, i.e., in thechannels that close in response to light (Pugh et al.,
1998). Thus, the decrease of the a-wave in Sca7266Q/5Q top layer of ONL (Carter-Dawson and LaVail, 1979; Rich
et al., 1997). To verify that the nuclei harboring mutantmice provides direct evidence for a rod photoreceptor
defect. The normal amplification constant suggests that ataxin-7 signals in the ONL of 10-week-old Sca7266Q/5Q
retina are those of cones, we double-labeled retina sec-this deficit is not due to a change in the relative enzy-
matic activities of the proteins involved in the transduc- tions with ataxin-7 antibody (1261) in combination with
neuron-specific enolase (NSE) antibody, which labelstion cascade. A loss of photoreceptors or decrease in
the photoreceptor outer segment length could diminish cones (Rich et al., 1997). All ataxin-7-positive nuclei in
ONL, at this age, turned out to be those of cones, sug-the a-wave amplitude without necessarily changing the
amplification constant. To determine whether the dys- gesting that accumulation of mutant ataxin-7 starts in
the cones in the ONL (Figure 4B). We also performedfunction extended to cones, we used the double flash
technique to isolate responses from cone photorecep- double labeling using 1261 antibody in combination with
either calbindin antibody (a marker for horizontal cellstors (Lyubarsky et al., 1999). Figures 2M–2P show the
ERG response to a white flash, which stimulates both and amacrine cells) or protein kinase C (PKC) antibody
(a marker for bipolar cells) on 10-, 12-, and 15-week-S and M cones. To establish whether there was any
Neuron
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Figure 1. Generating Sca7266Q/5Q Mice
(A) Targeting scheme. The top diagram shows a simplified version of mouse Sca7 locus near exons 3 and 4. Targeting construct introduced
266 CAG repeats (inverted triangle) and flanking regions from human SCA7 into exon 3, obtaining a targeting frequency of 4%. Electroporation
of Cre recombinase into the positive ES clones allowed the excision of the Neomycin (Neo)/Thymidine kinase (Tk) selection cassette (shown
as an open box) from the targeted locus. P indicates a probe used for Southern analysis. Red arrowheads indicate loxP sites. Abbreviations
are as follows: 3, exon 3; 4, exon 4; 3e, engineered exon 3 with 266 CAG repeats; RV, EcoRV; RI, EcoRI; S, ScaI; and B, BamHI.
(B) Germline transmission of a targeted allele. Southern analysis of EcoRI-digested tail DNA revealed 15.2 kb wild-type and 10.3 kb mutant
bands in Sca7266Q/5Q mice. Only the 15.2 kb band was detected from wild-type (WT) mice.
(C) Ataxin-7 is predominantly nuclear in the cerebellum, and expanded ataxin-7 is expressed in vivo. Both wild-type and mutant
Pathogenic Effects of Mutant Ataxin-7 in SCA7 Mice
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old retina sections (Figure 4C and data not shown) and CRX dysfunction might not be the primary and/or sole
mediator of cone-rod dystrophy in SCA7. Transcriptionalconfirmed that the mutant protein accumulated in nuclei
of all three interneurons in INL. dysregulation in Sca7266Q/5Q retina might arise from more
global repression of photoreceptor-specific genes.Although NIs were present in all three nuclear layers
in the retina, apoptosis was observed only in ONL (Figure
4D). More importantly, retinal dysfunction occurred prior Cerebellar Dysfunction in Sca7266Q/5Q Mice
In addition to the retina, the cerebellum is one of the mostto the loss of photoreceptors: both rod and cone activi-
ties were significantly reduced at 9 weeks (Figure 2), commonly affected tissues in infantile SCA7. Sca7266Q/5Q
mice manifested motor incoordination on the rotarod bybut only few photoreceptors were TUNEL positive in
ONL of 10-week-old Sca7266Q/5Q mice (Figure 4D). To 5 weeks. Although their rotarod performance improved
with training, they did not last as long on the rotarod asquantify the loss of photoreceptors, we counted the
number of nuclei in the vertical length of ONL (see Exper- their wild-type littermates (Figure 6A). By 8–9 weeks,
gait ataxia was apparent and motor coordination deteri-imental Procedures) at 15 weeks of age. Sca7266Q/5Q mice
lost about 20% of photoreceptors in the ONL at this age orated further. Mutant mice soon became kyphotic, then
hypoactive at the terminal stage of disease. Pathologic(WT, 10.9  0.1; Sca7266Q/5Q, 8.8  0.11; p  0.0001). We
also observed progressive activation of Mu¨ller glia in inspection of Sca7266Q/5Q brain revealed that it was smaller
than wild-type. TUNEL assays at 15 and 18 weeks de-Sca7 266Q/5Q retina, which is a good indicator for photore-
ceptor degeneration (Semple-Rowland et al., 1991; de tected no positive signals in cerebellum (data not
shown). In order to evaluate whether there was any lossRaad et al., 1996; Hong et al., 2000; Rattner et al., 2001)
(Figure 4E). Our results indicate that the abnormal ERGs of Purkinje cells in Sca7266Q/5Q cerebellum at the terminal
stage, we counted the number of Purkinje cells in a 5in Sca7266Q/5Q mice are not due to the loss of photorecep-
tors, but to photoreceptor dysfunction and transcrip- m section through the midsagittal cerebellar region at
18 weeks. No significant Purkinje cell loss was detectedtional dysregulation of photoreceptor-specific genes.
in the mutants (WT, 273.3 5.8; Sca7266Q/5Q, 264.3 8.6;
p  0.2), which is consistent with the findings in someCRX Dysfunction in SCA7 Revisited
La Spada et al. recently observed that CRX interacts infantile SCA7 cases (Carpenter and Schumacher,
1966). Immunofluorescence confocal microscopy re-with ataxin-7, and proposed that mutant ataxin-7 inter-
ference with CRX function causes the cone-rod dystro- vealed that although the number of Purkinje cells and
their dendritic arbors appeared normal in 16-week-oldphy in SCA7 (La Spada et al., 2001). In agreement with
previous work on SCA7 transgenic mice, CRX-regulated Sca7266Q/5Q cerebellum, the cell bodies were significantly
smaller than those of wild-type Purkinje cells (Figuresphotoreceptor-specific genes such as Bcp, Gcp, Rho,
and Gnat1 were downregulated in Sca7266Q/5Q mice. But 6B and 6C).
Rhok, which is not altered in Crx-deficient mice (Furu-
kawa et al., 1999), was also progressively downregu- Mutant Ataxin-7 Is Highly Insoluble and Gradually
Accumulates in Neuronslated in Sca7266Q/5Q mice (Figure 3A). Furthermore, we
found that CRX protein levels did not change up to 14 No ataxin-7 immunostaining was apparent in wild-type
brain sections with the 1261 antibody made againstweeks of age in Sca7266Q/5Q retina (Figure 5A). Electropho-
retic mobility shift assays (EMSAs) showed that CRX amino acid 1–19 of human ataxin-7 (kind gift of J.-L.
Mandel [Lindenberg et al., 2000; Yvert et al., 2000]) andbinding to Ret-4, a well-characterized CRX-responsive
element in the bovine rhodopsin promoter (Chen and SCA7 (1-135) antibody made against amino acid 1–135
of mouse ataxin-7 (kind gift of M. Holmberg [Stro¨m etZack, 1996), was the same as wild-type in 3- to 7-, 10-,
and 12-week-old Sca7266Q/5Q retina (Figure 5B and data al., 2002]) (Figure 7A and data not shown). The same
antibodies were, however, able to detect mutantnot shown). To further probe the role of CRX dysfunction
in Sca7266Q/5Q mice, we analyzed the expression levels of ataxin-7 in Sca7266Q/5Q brain, and the staining became
denser as the animal aged (Table 3; Figure 7A). Theadditional genes that are not altered (Rom1 and Rbp3)
as well as a gene that is upregulated (Cnga3) in Crx/ pattern of immunoreactivity varied, however, in different
neurons. NIs did appear in nonaffected areas (areas thatmice based on Northern analyses (Furukawa et al., 1999)
(Figure 5C). Rom1 encodes retinal outer segment mem- are typically spared in infantile SCA7 patients [Havener,
1951; Carpenter and Schumacher, 1966]) first; however,brane protein 1 (Rom1), which is a structural component
of rod photoreceptor outer segments (Goldberg and they were in glial cells and not in neurons. Neurons of
the retina and cerebellum, two areas whose functionsMolday, 1996), and Rbp3 encodes interphotoreceptor
retinal binding protein (IRBP). Cnga3 encodes cGMP- are profoundly affected in infantile SCA7 patients and
Sca7266Q/5Q mice, showed faster accumulation of mutantgated cone channel. All these genes were progressively
downregulated in Sca7266Q/5Q mice in contrast with Crx ataxin-7 than other areas of the brain in Sca7266Q/5Q mice.
It is interesting that although mutant ataxin-7 accumula-null mice where they were either upregulated or unal-
tered (Figures 5C and 5D). These results suggest that tion increased over time, NIs were not formed until much
ataxin-7 are present only in the nuclear extracts of 7-week-old mice. Mutant ataxin-7 immunoreactivity is observed in the stacking gel. N and
C are nuclear and cytoplasmic extracts, respectively.
(D) 16-week-old WT and Sca7266Q/5Q mice. At this age, mutant mice weigh only 50% of wild-type counterparts and are extremely hypoactive.
Tremor is triggered whenever they initiate movement. Ptosis and kyphosis are apparent in mutant mouse shown here.
(E) Both male and female Sca7266Q/5Q mice show retarded growth after 5 weeks of age.
Neuron
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later in the disease course (10–12 weeks) in these two
affected areas (Figures 3C, 4A, and 7A). This accumula-
tion of mutant ataxin-7 was not due to the upregulation
of mutant Sca7 mRNA, since there was no difference
between the level of mutant and wild-type Sca7 mRNA
in the mutant brain (Figure 7B).
The hippocampus was another area where accumula-
tion of mutant ataxin-7 in neurons was occurring around
the same time as the retina and cerebellum, which
prompted us to search for functional impairments spe-
cific to this tissue (see below). It is noteworthy that in three
areas that develop functional impairments in Sca7266Q/5Q
mice (retina, cerebellum, and hippocampus), the aggre-
gates became ubiquitin positive around 12 weeks (Table
3). Ubiquitin-positive NIs colocalized with Hsc70, and
the number of ubiquitin- and Hsc70-positive NIs in-
creased over time (data not shown). No CRX or TATA
binding protein (TBP) immunoreactivity was observed
in NIs of affected neurons up to 18 weeks (Table 3).
NIs throughout the brain became CREB binding protein
(CBP) positive around 18 weeks (Table 3).
Wild-type ataxin-7 was detected only in nuclear ex-
tracts, but not cytoplasmic extracts of wild-type and
Sca7266Q/5Q cerebella (Figure 1D). We failed to detect any
SDS-soluble mutant ataxin-7 or any evidence of trun-
cated mutant ataxin-7 using N-terminal (1261) and
C-terminal (1597) (Yvert et al., 2000) antibodies in the
separating gel (Figure 1C and data not shown). Mutant
ataxin-7 was detected only in the stacking gel, sug-
gesting that this protein exists as an insoluble multimer
or in complexes with other proteins. Another possibility
is that the conformation of soluble mutant ataxin-7 dif-
fers from that of insoluble mutant ataxin-7, and the epi-
tope of soluble mutant ataxin-7 is masked. We reasoned
that because the mutant protein accumulated with age,
we might be able to detect the soluble form in younger
animals. Cerebellar nuclear extracts were prepared from
2-, 5-, 7-, 10-, 12-, and 15-week-old Sca7266Q/5Q mice,
and Western blotting was performed using the 1261
antibody. Expression levels of wild-type ataxin-7 were
very low in both wild-type and Sca7266Q/5Q mice, and mu-
tant ataxin-7 immunoreactivity in the stacking part of
the gel increased with age. Surprisingly, we were unable
to detect the soluble mutant ataxin-7 even in 2-week-
old mice when very faint immunoreactivity was found
in the stacking gel. This suggests that there is little
accumulation of mutant ataxin-7 at this age. These data
indicate that even in 2-week-old Sca7266Q/5Q cerebellum,
soluble mutant ataxin-7 might exist in a conformation
that is not easily detectable with 1261 antibody or that
it is still efficiently turned over. By 5 weeks, however,
mutant ataxin-7 begins to accumulate, becoming part
of insoluble complexes.
Selective Impairment of PTP
We investigated hippocampal function in Sca7266Q/5Q
mice, since the hippocampus is another area in which
mutant ataxin-7 rapidly accumulated in neurons (Table
3; Figure 8A). Occasional punctate nuclear immuno-
staining of ataxin-7 was observed in hippocampal CA1
pyramidal neurons around 12 weeks, and by 15 weeks,
NIs became larger and dotted the entire hippocampus
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(Figure 8A and data not shown). We investigated
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Figure 2. Representative ERGs from Wild-Type and Sca7266Q/5Q Mice
The first column contains data from wild-type mice, while subsequent columns show data from Sca7266Q/5Q mice at increasing ages.
(A–D) Measurement of the scotopic b-wave. Traces were obtained using a series of 500 nm flashes with intensities ranging from3.86 to1.76
log scotopic cd-s/m2 (estimated to produce between 0.13 and 16.1 photoisomerizations/rod in photoreceptors with normal outer segments).
Each trace represents the average of at least five flashes.
(E–H) ERG response to an intense flash (2.92 log scotopic cd-s/m2 or an estimated 800,000 photoisomerizations/rod).
(I–L) a-wave response to flashes varying in intensity from 0.51 to 2.92 log scotopic cd-s/m2 (290–800,000 photoisomerizations/rod). Traces
have been fit using the Lamb-Pugh model, as described in Experimental Procedures.
(M–P) Cone isolated ERGs using the double flash method. Only the response to the second white flash is displayed. To distinguish between
S cones and M cones, the second flash was filtered at 365 nm (Q–T) and 500 nm (U–X). M cones were affected before S cones. Progressive
decreases in scotopic b-waves, a-waves, and cone-driven b-waves indicate retinal dysfunction in Sca7266Q/5Q mice.
whether synaptic physiology was altered at the time of Sca7266Q/5Q mice and littermate controls and character-
ized synaptic transmission and short- and long-termmutant ataxin-7 accumulation in hippocampal area CA1.
We prepared hippocampal slices from 12-week-old plasticity using extracellular field recordings in stratum
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Figure 3. Retinal Degeneration in Sca7266Q/5Q Mice
(A) Progressive downregulation of photoreceptor-specific genes in Sca7266Q/5Q eyes. Expression levels of five photoreceptor-specific genes
using total RNAs from WT and Sca7266Q/5Q mice show a progressive decrease with age. The expression of cone-specific genes (Bcp and Gcp)
diminishes before the rod-specific genes (Rho and Gnat1) and decreases more rapidly with time. Signals from each lane were normalized to
Gapdh, and ratios were calculated relative to that of the WT at each age.
(B) Shortening of the outer segment in Sca7266Q/5Q retina. The retinal layer thins with age, mainly due to the thinning of the IPL. At 10 weeks,
the outer segments in mutant mice become more dispersed than WT. Shortening of the outer segments continues as mice age, and after 12
weeks, the outer segments are no longer detectable in Sca7266Q/5Q retina. Abbreviations for each retinal layer are as follows: PE, pigment
epithelium; OS, outer segment; IS, inner segment; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner
plexiform layer; and GCL, ganglion cell layer.
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Table 3. Time-Dependent Appearance of NIs in the Brain and Retina
NIa Appearance Ub-Positive Hsc70-Positive CBP-Positive TBP-Positive
Area (Weeks) Staining (Weeks) Staining (Weeks) Staining (Weeks) Staining (Weeks)
Spinal cordb 5 12 12 18 -
Pons/Medullab 5 12 12 18 -
Olfactory bulbb 7 15 15 18 -
Cortexb 5 12 15 18 -
Cerebellum 12 12 12 18 -
Hippocampus 13 13 13 18 -
Retina 8 12 12 - -
a Here used to denote any visible aggregation, including microaggregates.
b In these tissues, NIs appeared in glial cells at the designated ages.
radiatum in area CA1. We detected no difference in receptor-independent LTP in Sca7266Q/5Q mice. Similar to
the NMDA receptor-dependent LTP results, there wasbaseline synaptic transmission, as input-output func-
no difference in NMDA receptor-independent LTP be-tions for increasing stimulus intensities in Sca7266Q/5Q
tween wild-type and Sca7266Q/5Q mice, and again a signifi-mice are similar to wild-type (Figure 8B). Normal baseline
cant reduction in the first few minutes of LTP was ob-synaptic transmission suggests that the synaptic con-
served (Figure 8G). Our data suggest that the I-LTPnectivity in Sca7266Q/5Q mice is normal. Paired pulse facili-
impairment in Sca7266Q/5Q mice is not restricted to stimu-tation (PPF), a form of short-term synaptic plasticity, was
lation in the 100 Hz frequency range, but is observed atslightly elevated in Sca7266Q/5Q mice, with the greatest
higher stimulation frequencies (200 Hz) as well. Deficitsdifference at 30 ms interpulse interval (Sca7266Q/5Q,
in Sca7266Q/5Q I-LTP or PTP do not appear to be due158%  1%; WT, 135%  4%), but PPF across all in-
to changes in baseline synaptic responses since EPSPterpulse intervals did not show statistically significant
wave forms from CA1 field recordings were indistin-differences (Figure 8C).
guishable from those of controls (Figure 8H).Synaptic enhancement of the Shaffer collateral syn-
We could not assess whether there was a behavioralapse following high-frequency stimulation (HFS) can be
correlate to this physiology because by 12 weeks of agedivided into three distinct phases: (1) initial LTP (I-LTP)
the mutant mice were so deteriorated, and their vision(commonly referred to as short-term potentiation [STP]),
so compromised, that it was impossible to ascertain(2) early LTP (E-LTP), and (3) late LTP (L-LTP) (Sweatt,
which behaviors might be due to hippocampal dys-1999). Sca7266Q/5Q mice showed a significant reduction
function.in I-LTP (indicated by the asterisk in Figure 8D), following
the LTP-inducing HFS using a standard two trains of
Discussion100 Hz stimulation (Figure 8D), but normal E-LTP. We
tested whether the same LTP impairment could be seen
To produce an authentic model for SCA7, we generated
in Sca7266Q/5Q mice under the saturating HFS paradigm.
mice bearing a CAG repeat length that causes infantile-
LTP was induced in Sca7266Q/5Q mice with three pairings onset SCA7 in humans. Sca7266Q/5Q mice developed most
of 100 Hz stimulation (6, 100 Hz trains total) (Figure of the salient features of the human disease. It is note-
8E). This clearly shows that Sca7266Q/5Q mice are capable worthy that, although SCA7 is an autosomal dominant
of maximum potentiation under saturating HFS. Consis- disease, Sca7266Q/266Q mice have a more accelerated phe-
tent with our previous result, there was a significant notype than Sca7266Q/5Q mice, indicating a gene dosage
reduction in I-LTP following the first pairing of stimula- effect. Homozygosity in SCA7 has never been reported,
tion, but the deficit in I-LTP could be rescued with suc- but homozygosity in other polyglutamine diseases such
cessive pairings of 100 Hz stimulation (Figure 8E). A as MJD/SCA3, SCA6, and DRPLA advances the age of
prominent component of I-LTP is posttetanic potentia- onset and increases disease severity (Kawakami et al.,
tion (PTP), a short-lived form of presynaptic plasticity 1995; Lang et al., 1994; Sobue et al., 1996; Takiyama
immediately following HFS, characterized by greatly en- and Tsuji, 1995; Kato et al., 2000; Sato et al., 1995).
hanced potentiation lasting for 1–5 min. In order to iso- Because expanded polyglutamine tracts lend deleteri-
late the PTP component from I-LTP, the NMDA receptor ous properties to mutant proteins, higher levels of mu-
antagonist 2-amino-5-phosphonovaleric acid (AP-5) tant proteins exacerbate the toxic effects.
was used to mask postsynaptic potentiation but leave
PTP intact. Using this protocol, we found that the Infantile SCA7 Clinical Phenotype
changes in I-LTP in Sca7266Q/5Q mice were due in part Expansions ranging from 200 to 460 CAG repeats invari-
ably cause infantile-onset SCA7 in humans. Infantileto a deficit in PTP (Figure 8F). We also tested NMDA
(C) Wild-type ataxin-7 is hardly detectable in WT retina, and NIs in Sca7266Q/5Q retina appear after the functional impairments. 1261 antibody
did not detect wild-type ataxin-7 in WT retina. Mutant ataxin-7 staining, however, began to appear around 8 weeks of age as microggregates
in Sca7266Q/5Q retina. Retinas of 12- and 18-week-old Sca7266Q/5Q mice shown reveal NIs in PE, ONL, INL, and GCL. The size and frequency of
NIs increase as animal ages. NIs in INL is shown in insets (red boxes).
Scale bar indicates 50 m. There is no difference among the 10-, 12-, 15-, and 18-week-old WT retina; therefore, only the retina from one
stage is shown in (B) and (C) for WT.
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Figure 4. NIs and Apoptosis in Sca7266Q/5Q Retina
(A) NIs in Sca7266Q/5Q start predominantly in the top layer of ONL and throughout the INL. Immunofluorescence of 1261 antibody shows the
distribution of NIs in Sca7266Q/5Q retina. The size and frequency of NIs increase over time.
(B) In ONL, the nuclei of cones are the ones where NIs develop first. Double labeling using 1261 antibody (red) and NSE antibody (green)
shows the colocalization of mutant ataxin-7 and NSE in cones of 10-week-old Sca7266Q/5Q retina.
(C) NIs colocalize with horizontal cells and amacrine cells in INL. Double labeling using 1261 antibody (red) and calbindin antibody (green)
shows NIs in horizontal cells and amacrine cells of retinas from 15-week-old mice. NIs are also observed in displaced amacrine cells in GCL.
(D) Apoptosis of photoreceptors occurs after photoreceptor dysfunction. TUNEL-positive signals (green) were found in ONL. Very few TUNEL-
positive photoreceptors are seen at 10 weeks when ERG data indicate that there is a significant reduction in both cone and rod activities.
(E) Progressive activation of Mu¨ller glia in Sca7266Q/5Q retina. Retina sections were stained with GFAP antibody to demonstrate gliosis in Sca7266Q/5Q
retina.
Scale bar indicates 50 m. There is no difference between the 10- and 15-week-old WT retina; therefore, only the retina from one stage is
shown in (D) and (E) for WT.
SCA7 not only shows an extremely rapid progression than that of adult-onset disease. In addition to ataxia,
muscle wasting, kyphosis, ptosis, cone-rod dystrophy,(children develop symptoms shortly after birth and die
within 1–2 years), but the phenotype is much broader and tremors, these infants can suffer from severe hypo-
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Figure 5. CRX and Retinal Dysfunction in Sca7266Q/5Q Mice
(A) CRX levels do not change in 9- and 14-week-old Sca7266Q/5Q retinas. Retinal protein extracts were prepared from 9- and 14-week-old mice.
CRX antibody did not detect any difference in CRX level between WT and Sca7266Q/5Q mice. GAPDH antibody was used as a loading control.
(B) EMSAs for detecting DNA binding activity of CRX in the retina of WT and Sca7266Q/5Q mice show that CRX binding to Ret-4 is not altered
in Sca7266Q/5Q retina. Ret-4 is known to be recognized by CRX and an unidentified ubiquitously expressed protein (U). Nuclear extracts were
prepared from WT and Sca7266Q/5Q retinas at 6 and 10 weeks. 1.2 g of retinal nuclear extracts were incubated with 1 nM of a 32P-labeled Ret-4
probe in the presence of either 0.01 or 0.1 g of poly dI-dC (Pharmacia). The binding activity of CRX was confirmed by the loss of the CRX
band (labeled by an arrow), coinciding with the appearance of a supershift when 1 l (0.5 g) of the CRX antibody p261 (La Spada et al.,
2001) was included in the EMSA reactions (lanes 3, 6, 9, and 12). The intensity of CRX-bound bands is similar between the WT and Sca7266Q/5Q
lanes, indicating that there is no difference in CRX binding to its target site.
(C) Gene expression alterations in Sca7266Q/5Q mice. Genes that are not altered (Rom1 and Rbp3) and a gene that is upregulated (Cnga3) in
Crx/ mice are all progressively downregulated in Sca7266Q/5Q retina.
(D) Venn diagram summarizing the patterns of photoreceptor-specific gene expression in Crx/ and Sca7266Q/5Q mice. Genes that are downregu-
lated in both mouse models are shown in purple. Direction of each arrow indicates increase (up arrow) and decrease (down arrow) in gene
expression, respectively.
tonia, myoclonic seizures (Colan et al., 1981; Yoo and The limited cell loss in infantile cases is attributable to
extremely short duration of the disease: neuronal dys-Zoghbi, 2002), and noncentral nervous system dysfunc-
tion such as congestive heart failure (Benton et al., 1998; function leads to demise before significant numbers of
cells are lost.Johansson et al., 1998; van de Warrenburg et al., 2001).
Some autopsy studies show cerebellar atrophy and loss
of Purkinje cells similar to those seen in adult SCA7
patients, but other infantile patients have grossly normal The Sca7266Q/5Q Phenotype
Sca7266Q/5Q mice are strikingly similar in phenotype to anbrains (Carpenter and Schumacher, 1966). Brainstem,
spinal cord, and optic nerves appear normal in infantile infant in the BASCA kindred who bore a similar number
of CAG repeats (Benton et al., 1998). This infant showedcases, and the retinal pathology is confined to outer
segment loss, leaving other areas of the retina intact symptom onset at about 1 month of age; Sca7266Q/5Q mice
became distinguishable from their wild-type littermates(Ryan et al., 1975; de Jong et al., 1980; Traboulsi et al.,
1988). Some infantile patients show loss of photorecep- (by showing motor incoordination) at 5 weeks. The signs
of disease that developed in the knockin mouse paral-tors in the foveal and parafoveal areas of the ONL (Ryan
et al., 1975; de Jong et al., 1980; Traboulsi et al., 1988). leled features of this patient in kind and progression (see
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Figure 6. Sca7266Q/5Q Mice Show Impaired Rotarod Performance but No Purkinje Cell Loss
(A) 5-week-old male and female Sca7266Q/5Q mice have motor incoordination on a rotarod assay. 7 wild-type and 12 heterozygous male mice
were tested, and 10 wild-type and 8 heterozygous female mice were tested.
(B) Confocal microscopy of anticalbindin-labeled Purkinje cells of 16-week-old Sca7266Q/5Q shows shrinkage of Purkinje cell bodies but no other
distinct defects in mutant cerebellum. Scale bar  50 m.
(C) The boxed portions in (B) are magnified to better show the size difference of cell bodies. Scale bar  50 m.
(D) Purkinje cells from 16-week-old Sca7266Q/5Q mice have smaller cell bodies.
Table 1). Finally, some of the mutant mice developed these mutants is quite distinct from that of SCA1 knockin
mice (Watase et al., 2002): SCA1 knockin mice showmyoclonic seizures, as do some infantile SCA7 patients.
The Sca7266Q/5Q mice thus show remarkable parallels reduced dendritic arborization of Purkinje cells, but the
Sca7266Q/5Q mice, which have apparently normal dendriticto the human disease. It is also important to note that
the pattern of cerebellar Purkinje cell degeneration in arbors, have smaller than normal soma (Figures 6C and
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Figure 7. Progressive Accumulation of Mu-
tant Ataxin-7 in Sca7266Q/5Q Mice
(A) Wild-type ataxin-7 is not detectable in
wild-type cerebellum, but mutant ataxin-7
gradually accumulates in the nuclei of cere-
bellar Purkinje cells in Sca7266Q/5Q mice. Mi-
croaggregates are formed around 12 weeks
of age. These aggregates later develop into
single, large NIs. Black arrow and red arrow-
head indicate NI and vacuole in Purkinje cells,
respectively. Scale bar  50 m.
(B) The level of mutant Sca7 transcript is not
different from wild-type in Sca7266Q/5Q brain.
Total RNA was prepared from mouse brain
at indicated ages. 7.5 kb wild-type Sca7 tran-
script is detected in both wild-type and
Sca7266Q/5Q mice. 8.3 kb mutant Sca7 tran-
script is detected only in Sca7266Q/5Q lanes.
(C) Mutant ataxin-7 is detected only in the
stacking gel. 1261 antibody detected both
wild-type ataxin-7 and mutant ataxin-7. The
amount of mutant ataxin-7 in stacking gel in-
creases over time.
6D). This difference points to the importance of protein ening and loss of rod photoreceptor activity (Humphries
et al., 1997). Thus, shortening of outer segments incontext for determining specific aspects of the phe-
notype. Sca7266Q/5Q mice might be attributable to the downregula-
tion of photoreceptor-specific genes such as three pho-
topigments (Bcp, Gcp, and Rho) and structural compo-Retinal Dysfunction in Sca7266Q/5Q Mice
nents of outer segments such as Rom1 and Prph2ERG studies of SCA7 patients show that cone dysfunc-
(coding for Peripherin) (Figures 3A and 5C; data nottion occurs prior to rod dysfunction, and both cone- and
shown).rod-driven ERGs gradually decrease with age (de Jong
It is interesting that although our ERG results parallelet al., 1980; Colan et al., 1981; Neetens et al., 1990;
those of the groups that generated SCA7 transgenicTo et al., 1992). Sca7266Q/5Q mice undergo normal retinal
mice (Yvert et al., 2000; La Spada et al., 2001), the pathol-development, but with increasing age beyond 5 weeks,
ogy of the transgenics is markedly worse: their ONLthey manifest ptosis and visual impairment. Our ERG
becomes disorganized as they age, forming a “wavy”data showed that cone dysfunction preceded rod dys-
pattern. The transgenics also show significant photore-function in these mutants, and M cones were affected
ceptor loss. In contrast, Sca7266Q/5Q mice did not showbefore S cones (Figure 2). Northern analyses paralleled
much cell loss in the ONL (Figure 3B); apoptosis beganthe ERG data in that the cone-specific markers were
around 10 weeks of age (Figure 4D), but these mutantsdownregulated before the rod-specific markers, and
retained more than 80% of the photoreceptors until theGcp downregulation occurred faster than Bcp (Figure 3A).
terminal stage of the disease. Loss of outer segmentsLike infantile SCA7 patients, Sca7266Q/5Q mice showed
will eventually lead to the death of photoreceptors, butprogressive shortening of the outer segments (Figure
the short life span of the Sca7266Q/5Q mice precluded a3B). The outer segments are delicate structures con-
significant loss of cells in either the retina or the cerebel-taining proteins involved in the phototransduction cas-
lum, much like the infantile SCA7 patients. Clearly, outercade which are continuously renewed as the discs at
segment loss and altered gene expression are the earli-the distal end are shed and phagocytosed by retinal
est pathogenic events.pigment epithelial cells (Morrow et al., 1998; Pierce,
We were intrigued by the idea that CRX dysfunction2001). Degeneration of outer segments results in blind-
may be responsible for cone-rod dystrophy in SCA7 (Laness (Morrow et al., 1998). Mice with a targeted deletion
of Rho showed a similar pattern of outer segment short- Spada et al., 2001). Transcription of Bcp, Gcp, Rho, and
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Figure 8. Reduced PTP in Sca7266Q/5Q Mice
(A) Wild-type ataxin-7 is barely detectable in
wild-type hippocampus. Mutant ataxin-7 ac-
cumulates in nuclei of hippocampal CA1 py-
ramidal neurons and starts to form a punctate
staining around 12 weeks of age, and the size
and frequency of NIs increase with age.
(B) Sca7266Q/5Q mice show normal baseline
synaptic transmission in the stratum radiatum
of the CA1 region of the hippocampus, mea-
sured at 30C (n 7 for wild-type and mutant
animals).
(C) Short-term plasticity assessed by PPF is
unaffected in Sca7266Q/5Q mice.
(D) Sca7266Q/5Q hippocampal slices show re-
duced PTP (Sca7266Q/5Q, 162%  13.4%, n 
10; WT, 216%  17.1%, n  10; p  0.022),
but normal LTP induction 60 min posttetanus
(Sca7266Q/5Q, 158%  14.8%; WT 165% 
4.5%) when induced with a standard HFS
protocol consisting of two trains of a 1 s long,
100 Hz stimulation.
(E) PTP in Sca7266Q/5Q mice is rescued follow-
ing the successive trains of 100 Hz stimula-
tion. First train (Sca7266Q/5Q, 165% 8.6%, n
11; WT, 198.2%  9.6%, n  6; p  0.045).
Second train (Sca7266Q/5Q, 202% 13.2%; WT,
204%  10.1%). Third train (Sca7266Q/5Q,
209%  13.4%; WT, 201%  9.1%).
(F) A closer examination of PTP was per-
formed using a single train of 100 Hz stimula-
tion in the presence of the NMDA receptor
antagonist AP-5 (application is represented
with a black bar), and pEPSPs were recorded
every 12 s. Sca7266Q/5Q mice show a significant
reduction in PTP immediately following HFS
(Sca7266Q/5Q, 135% 5.7%, n 7; WT, 178%
16.5%, n  5; p  0.02)
(G) NMDA receptor-independent LTP in-
duced using one train of 200 Hz stimulation
for 1 s in the presence of AP-5 (application
is represented with a black bar) also shows
reduced PTP (Sca7266Q/5Q, 137%  5.4%, n 
10; WT, 170%  13.6%, n  10; p  0.036).
Results are shown as mean  SEM.
(H) Representative traces (mean of six aver-
aged successive pEPSPs, scale bars repre-
sent 1mV and 10 ms) showing differences in
baseline pEPSPs compared to pEPSPs dur-
ing PTP (immediately following 100 Hz HFS).
Gnat1 are controlled by CRX (Furukawa et al., 1999), at 4 weeks of age, which improve at 8 weeks and are
normal by 6 months of age (Furukawa et al., 1999).and we knew that these genes were all progressively
downregulated in Sca7266Q/5Q mice—but Rhok, a gene Sca7266Q/5Q mice, on the other hand, had normal rod ERGs
at 5 weeks, did not show any improvement of the retinalthat is not altered in Crx/ mice, was also downregu-
lated in Sca7266Q/5Q mice (Figure 3A). This led us to con- function with age, but rather a deterioration over time
(Table 2; Figure 2). In addition, Crx	/ mice do not showsider the possibility that other factor(s) might also be
involved in the downregulation of photoreceptor-spe- the same type of dysregulation of photoreceptor-spe-
cific genes observed in Sca7266Q/5Q mice; although down-cific genes in the Sca7266Q/5Q retina. Further expression
analysis of more photoreceptor-specific genes (Figures regulation of Bcp was observed in Crx	/ mice, Gcp
was upregulated (Furukawa et al., 1999). The difference5C and 5D) lent support for this hypothesis: genes that
are either upregulated or unaltered in Crx/ mice were in the retinal phenotypes of Sca7266Q/5Q mice and Crx
haploinsufficient mice argue that a simple model pro-all progressively downregulated in Sca7266Q/5Q mice.
Crx	/ mice with only one functional Crx allele show posing that polyglutamine expansion in ataxin-7 re-
duces CRX activity by 2-fold or less is excluded.delayed maturation of their photoreceptors as mani-
fested by the abnormal ERGs (both cone and rod ERGs) CRX protein levels did not change in Sca7266Q/5Q retina
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up to 14 weeks (Figure 5A), when the retinal dysfunction tissues of an early juvenile-onset SCA7 patient (Mauger
et al., 1999). Likewise, Yvert et al. could not detect wild-was pronounced. Moreover, CRX did not colocalize with
NIs in Sca7266Q/5Q retina (data not shown). Because pro- type ataxin-7 in their SCA7 transgenic mice, but had
no trouble detecting mutant ataxin-7 using the sametein activity can change without any alteration in levels,
we investigated the activity of CRX using EMSAs (Figure promoter (Yvert et al., 2001).
Mutant ataxin-7 accumulated ubiquitously in various5B). CRX binding to Ret-4 did not differ from wild-type
in Sca7266Q/5Q retina at 3–7, 10, and 12 weeks. Lastly, it neuronal subtypes in the brain and retina as Sca7266Q/5Q
mice aged; however, the speed of accumulation varied.is of note that while there is overlap in the alterations
seen in Sca7266Q/5Q mice and Crx null mice, there are some Neurons in affected areas showed much more rapid
accumulation of mutant protein than the ones in areasdifferences (Figure 5D). Cnga3 typically upregulated in
the Crx null mutants is downregulated in Sca7266Q/5Q mice; that are not obviously affected by disease. NIs devel-
oped in neurons only after sufficient amount of mutantRhok, Rom1, and Rbp3 which are spared in Crx nulls
are also downregulated in Sca7266Q/5Q mice. Although we protein was accumulated, and functional impairments
became manifest. Thus, as in SCA1 knockin mice (Wa-cannot rule out the possible alteration of CRX transacti-
vation in Sca7266Q/5Q retina, our data suggest that CRX tase et al., 2002), the NIs are unlikely to initiate neuronal
dysfunction. Indeed, NIs did not develop in the retinadysfunction might not be the primary and/or only cause
of retinal degeneration in SCA7. The compromise in CRX of Sca7266Q/5Q mice until after gene downregulation oc-
curred. This is not to say that NIs, once present, may notactivity observed in SCA7 transgenic mice (La Spada
et al., 2001) is probably brought out by the massive further stimulate the degeneration already in progress;
rather, it seems that it is the amount of mutant proteinoverexpression of the SCA7 transgene from a heterolo-
gous promoter. Similar results have been observed in rather than the presence of NIs per se that is critical to
cellular viability in SCA7 (the protein is no doubt accu-SCA1 mouse models: in SCA1 transgenic mice, down-
regulation of prenylcysteine carboxylnethyltransferase mulating in affected neurons before NIs become appar-
ent). We propose that certain neuronal groups mightgene (Pccmt) occurred at postnatal day 11 (Lin et al.,
2000), whereas it occurred after the onset of cerebellar have higher levels of proteins involved in refolding or
degrading mutant ataxin-7. Such differences would ex-dysfunction in SCA1 knockin mice (K. Watase and
H.Y.Z., unpublished data). The data from these models plain the selective neuronal vulnerability that character-
izes SCA7 and other polyglutamine diseases. Once NIsindicate that the early molecular changes in transgenics
might not accurately reflect what occurs in patients. developed in neurons, they were subsequently tagged
by ubiquitin and Hsc70 (Table 3). This suggests that, inWhat mechanism, then, underlies the retinal dysfunc-
tion in Sca7266Q/5Q mice? We propose that the accumula- addition to ataxin-7 accumulation, impaired clearance
of ubiquitinated proteins (ataxin-7 and perhaps othertion of mutant ataxin-7 results in progressive downregu-
lation of photoreceptor-specific genes, leading to the proteins) forms another layer of events late in this patho-
genic cascade. This may explain why late-stage disease,structural disorganization of outer segments, and thus,
to retinal dysfunction in Sca7266Q/5Q mice. It is noteworthy after ubiquitinated NIs appear, is associated with very
rapid deterioration: once the clearance system is over-that accumulation of mutant ataxin-7 in Sca7266Q/5Q retina
started in the cones and interneurons, spreading over to whelmed by accumulating protein, the additive effects
take over quickly.rods and ganglion cells later. Exactly how accumulated
mutant ataxin-7 leads to downregulation of photorecep-
tor-specific genes is not exactly determined yet. The Effects of Mutant Ataxin-7 on Short-Term
finding that several photoreceptor genes are downregu- Synaptic Plasticity
lated in Sca7266Q/5Q mice raises the possibility that The impairment in short-term synaptic plasticity in
ataxin-7 acts as a corepressor. Alternatively, mutant Sca7266Q/5Q mice is intriguing in that it is restricted to PTP
ataxin-7 might interfere with the activity of one or more and the first few minutes of LTP. Although not much is
transcriptional coactivators in the retina. known about the molecular events that underlie PTP,
it is thought to be generated by a prolonged rise in
presynaptic [Ca2	]i following HFS (Zucker and Regehr,Polyglutamine Expansion Does Indeed Impede
Mutant Protein Degradation In Vivo 2002). HD knockin mice show a PTP reduction as well,
but overall LTP and PPF are also decreased in theseAlthough the wild-type Sca7 transcript was abundantly
expressed in mouse brain (Figure 7B), the level of wild- mice (Usdin et al., 1999), suggesting that the PTP impair-
ment in Sca7 266Q/5Q mice is not caused merely by thetype ataxin-7 was very low (Figures 1C, 7A, 7C, and 8A).
Wild-type ataxin-7 may be rapidly turned over in vivo. presence of an expanded polyglutamine tract. Rather,
the expanded polyglutamine tract in the context ofMutant ataxin-7, on the other hand, progressively accu-
mulated in various neurons in Sca7266Q/5Q brain and retina ataxin-7 triggers this selective effect on short-term syn-
aptic plasticity, which could result either from a toxic(Figures 3C, 4A, 7A, 7C, and 8A). The level of wild-type
ataxin-7 may need to be maintained at low levels in gain-of-function of the mutant protein or from enhance-
ment of the endogenous function of ataxin-7 due to itsorder to tightly control its activity in these cells. The
polyglutamine expansion seems to stabilize the mutant stabilization. Further studies evaluating loss-of-function
effects and molecular interactions of ataxin-7 shouldprotein, slowing down its turnover rate and causing
downstream molecular events that hinder cell function provide insight into the molecular basis of this phe-
notype.and survival. Mauger et al. have, in fact, shown that the
level of wild-type ataxin-7 is too low to be detected with Sca7266Q/5Q mice bear a CAG tract that has been re-
ported in human patients and replicated the principletheir CM189 antibody in control tissues, while the same
antibody detected intense immunoreactivity as NIs in features of infantile SCA7 disease. Because the ex-
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Matlab (low pass filter, Fc  60 Hz). To calculate bmax,scot and I0.5, thepanded ataxin-7 was expressed in an accurate spatio-
peak value of each curve was fit to a saturating hyperbolic functiontemporal pattern, we were able to pinpoint the early
(Naka-Rushton). For analysis of the a-wave and cone function, 1500steps in pathogenesis. These mice will be valuable not
W Novatron xenon flash lamps provided intense illumination. To
only for exploring the mechanism of SCA7 and the effi- analyze the rod function, we used the following equation (Lamb-
cacy of therapeutic interventions, but will also help un- Pugh model) to fit a series of a-waves at increasing intensities:
veil the mechanism of PTP alterations and their physio-
logical significance. 1  a(t)
amax
 exp 12 · φ · A · (t  teff)2, (1)
Experimental Procedures where a(t) is the a-wave, amax is its saturating amplitude, φ is the
number of photoisomerizations rod produced by the flash, A is
Generating Sca7266Q/5Q Mice amplification factor, and teff is a brief delay. Because pathological
The 129/SvEv mouse genomic DNA library was screened using studies indicated that the outer segments were shorter in Sca7266Q/5Q
mouse EST clone W10624 (GenBank accession number), which is mice (Figure 3B), we substituted φ  I·k into the equation, and fit
homologous to the 5
 end sequence of human SCA7 exon 3. Two for the parameter kA (Hood and Birch, 1994). I is intensity in scotopic
clones (named 6A and 17A) were pulled out from this screen and cd/m2 and k is variable with units φ/scotopic cd/m2 . Cone-driven
were used to construct a targeting vector. hSCA7.forward (5
- responses were recorded using the paired flash technique. The first
TTGTAGGAGCGGAAAGAATGTC-3
) and hSCA7.reverse (5
-ATCACT flash drove the rods temporarily into saturation. The second flash,
TCAGGACTGGGCAGAG-3
) were used to PCR amplify 306 CAG delivered 2.5 s later, allowed the cones to recover, but not the rods.
repeats and flanking regions from the published patient sample To isolate responses from S cones or M cones, we used bandpass
(Benton et al., 1998). 100 ng of patient genomic DNA was used interference filters centered at 365 and 500 nm (Edmund Scientific),
in a 50 l reaction tube containing 50 M of each primer, 12.5% respectively. To remove oscillatory potentials prior to fitting, the
dimethylsulfoxide, 250 M each dNTP, 1.5 mM MgCl2, 50 mM KCl, cone b-wave was digitally filtered using the filtfilt function in Matlab
10 mM Tris-HCl (pH 8.3), and 4 U of Taq DNA polymerase. Cycling (low-pass filter, Fc  30 Hz).
conditions were as follows: 95C for 5 min followed by 35 cycles of
denaturing at 94C for 1 min, annealing at 62C for 1 min, extension Northern Blots
at 72C for 2 min, and final extension at 72C for 7 min. 198 bp NotI/ Total RNA was isolated from the mouse eyes and brain with TRIZOL
HindIII fragment of mouse Sca7 exon 3 was subcloned into pZErO reagent following manufacture’s instructions (Invitrogen). For ex-
2.0 (Invitrogen). In order to introduce ApaI site in position 153, this pression analyses of photoreceptor-specific genes, 10 g of total
clone was PCR amplified with M13 reverse primer and mSca7-ApaI RNA from eyes was loaded on each lane for electrophoresis and
primer (5
-GACGGCGGGCCCGGGGACACCACCACCTCG-3
). This transferred onto Hybond N	 nylon membrane (Amersham). All
changed 5
-GGCACC-3 into 5
-GGGCCC-3
 in position 150–155 of probes were obtained from the mouse EST clones (ATCC): Bcp
mouse Sca7. PCR product from the human patient sample was (GenBank accession number BG293946, 295–818 bp PstI/NheI frag-
double digested with NotI and Bsp120I (isoschizomer of ApaI) and ment), Gcp (GenBank accession number BG297657, 11–629 bp
ligated into the mouse Sca7 exon 3 with new ApaI site. Several NcoI/KpnI fragment), Rho (GenBank accession number BG296640,
subsequent ligation steps were followed to generate the Sca7 73–423 bp XhoI fragment), Gnat1 (GenBank accession number
knockin construct (19.8 kb). A selectable cassette containing the BG404720, 68–646 bp BstXI/BamHI fragment), Rhok (GenBank ac-
Neomycin resistance gene (Neo) and the Thymidine kinase gene cession number BG296640, 842–1387 bp KpnI/EcoRV fragment),
(Tk) flanked by two loxP sites was inserted into the SacI site, which Rom1 (GenBank accession number BG404693, 9–515 bp NarI frag-
is about 2.3 kb downstream from exon 4. The 306 CAG repeats were ment), Rbp3 (GenBank accession number BI737899, 846–1200 bp
highly unstable and contracted to 266 during the multiple ligation ApaI/BamHI fragment), and Cnga3 (GenBank accession number
steps. Sca7 knockin construct with 266 CAG repeats were electro- BI730059, 537–1364 bp, SmaI fragment). For Sca7 expression analy-
porated into embryonic stem (ES) cells, and subsequent electropor- ses, 15 g of total RNA from brain was loaded on each lane for
ation of Cre recombinase into the positive ES clones allowed the electrophoresis and transferred onto Hybond N	 nylon membrane
excision of Neomycin (Neo)/Thymidine kinase (Tk) selection cas- (Amersham). Probe was isolated from mouse Sca7 cDNA (360–912
sette. Correctly targeted ES cells were injected into C57BL/6J blas- bp HindIII/PstI fragment). Probes were labeled using Megaprime kit
tocysts to generate chimeras, which were crossed to C57BL/6J (Amersham) and hybridized in ExpressHyb hybridization solution
females to obtain Sca7266Q/5Q mice. Germline transmission of a tar- (Clontech) according to manufacture’s instructions. We measured
geted allele was confirmed using both tail DNA Southern analyses the intensity of each band by densitometry.
and PCR amplification of CAG repeats. PCR conditions were same
as above, and hSCA7.forward and mSca7.hybrid.reverse (5
-CCACCC Counting of the Number of Nuclei in the Vertical Length of ONL
ACAGATTCCACGAC-3
) were used as primers. Eyes of three mice were used for each genotype (five sections from
the center/mouse). Sections were cut in 5 m thickness. Pictures
Western Blot were taken at 20 magnification using a Zeiss Axioplan 2 fluores-
Nuclear and cytoplasmic extracts of mouse cerebellum were ob- cence microscope and Axiocam camera following Hematoxylin and
tained using NE-PER Nuclear And Cytoplasmic Extraction Reagents eosin staining. The number of vertical nuclei in ONL was counted
(Pierce). 100 g of protein was loaded on 6% SDS gel. Dilution every 25 m on these pictures (five to six counts were performed/
factor for 1261 was 1:1000. For expression analyses of CRX, retinal picture). Mean, SEM, and t test (two sample assuming unequal vari-
protein extracts were prepared by homogenizing mouse retinas in ance) were determined in Microsoft Excel.
buffer containing 100 mM Tris (pH 6.8), 25 mM DTT, 2% SDS, and
2 complete protease inhibitor cocktail (Roche). 20 g of extracts TUNEL Staining
were loaded on 10% SDS gel. Dilution factor for CRX antibody was Eyes were fixed in 4% PFA/PBS for overnight at room temperature
1:500. and cryoprotected by infiltrating from 15% sucrose/PBS to 30%
sucrose/OCT (Tissue-Tek). They were subsequently embedded in
OCT and cut as 10 m sections onto Superfrost/Plus slides (FisherElectroretinograms (ERGs)
Scientific). TUNEL assays were performed using In situ cell deathFlashes for scotopic measurements were generated by a Grass PS-
detection kit, AP following manufacture’s protocol (Roche). Images33	 photostimulator. Light was spectrally filtered with a 500 nm
were acquired by a Zeiss Axioplan 2 fluorescence microscope andinterference filter (Edmund Scientific). A series of metal plates with
Axiocam camera.holes of varying diameters and glass neutral density filters were
used to attenuate the flash. As the intensity of the flash increased,
the number of trials was decreased and the time between each flash Immunohistochemistry and Immunofluorescence
Immunohistochemical and immunofluorescent stainings were per-was increased. To remove oscillatory potentials prior to fitting, the
scotopic b-wave was digitally filtered using the filtfilt function in formed as previously described (Skinner et al., 1997; Cummings et
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al., 1999; Pennesi et al., 2003). Antibodies used: 1261 (1:200), mouse Received: July 12, 2002
Revised: December 17, 2002monoclonal Calbindin (Sigma, 1:1000), mouse monoclonal NSE
(Chemicon International, Inc., 1:200), rabbit polyclonal GFAP (Novus
Biologicals, 1:1000), mouse monoclonal Hsp70/Hsc70 (StressGen, References
1:200), mouse monoclonal Hsp70 (StressGen, 1:200), rabbit poly-
clonal Ubiquitin (StressGen, 1:300), mouse monoclonal CBP (Santa Benton, C.S., de Silva, R., Rutledge, S.L., Bohlega, S., Ashizawa,
Cruz, 1:200), mouse monoclonal TBP (QED Bioscience Inc., 1:1000), T., and Zoghbi, H.Y. (1998). Molecular and clinical studies in SCA7
and rabbit polyclonal TFIID (TBP) (Santa Cruz, 1:1000). define a broad clinical spectrum and the infantile phenotype. Neurol-
ogy 51, 1081–1086.
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(2000). Distribution of ataxin-7 in normal human brain and retina.on three to six serial midsagittal cerebella hemisphere 5m sections
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Carter-Dawson, L.D., and LaVail, M.M. (1979). Rods and cones inQuantifying Cell Body Size of Purkinje Cells
the mouse retina. I. Structural analysis using light and electron mi-15 m stacks of cerebellar optical sections were collected using a
croscopy. J. Comp. Neurol. 188, 245–262.Zeiss 510 confocal microscope and averaged using the z projection
function of NIH Image J. From three projected stacks (150 cells Chen, S., and Zack, D.J. (1996). Ret-4, a positive acting rhodopsin
each) for each of three wild-type and three Sca7266Q/5Q mice, a total regulatory element identified using a bovine retina in vitro transcrip-
of 450 wild-type and 450 Sca7266Q/5Q cells were outlined manually tion system. J. Biol. Chem. 271, 28549–28557.
and the cross-sectional area measured. Partial cells and binary cell Chen, S., Wang, Q.L., Nie, Z., Sun, H., Lennon, G., Copeland, N.G.,
images were excluded based upon cell shape and relative fluores- Gilbert, D.J., Jenkins, N.A., and Zack, D.J. (1997). Crx, a novel Otx-
cence intensity. Perikaryon area was estimated to be the approxi- like paired-homeodomain protein, binds to and transactivates pho-
mately circular area enclosed by the cell perimeter and the extension toreceptor cell-specific genes. Neuron 19, 1017–1030.
of the cell perimeter toward the initial point of dendrite extension.
Colan, R.V., Snead, O.C., and Ceballos, R. (1981). Olivopontocere-
bellar atrophy in children: a report of seven cases in two families.
Electrophoretic Mobility Shift Assays (EMSAs) Ann. Neurol. 10, 355–363.
Electrophoretic mobility shift assays were carried out as previously Cummings, C.J., Reinstein, E., Sun, Y., Antalffy, B., Jiang, Y., Ciecha-
described (Chen et al., 1997) using mouse retinal nuclear extracts nover, A., Orr, H.T., Beaudet, A.L., and Zoghbi, H.Y. (1999). Mutation
and a 32P-labeled probe containing Ret-4, a CRX binding site from of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency
the bovine rhodopsin promoter. while accelerating polyglutamine-induced pathology in SCA1 mice.
Neuron 24, 879–892.
Hippocampal Slice Preparation and Electrophysiology David, G., Abbas, N., Stevanin, G., Durr, A., Yvert, G., Cancel, G.,
Hippocampal slice preparation and electrophysiology were per- Weber, C., Imbert, G., Saudou, F., Antoniou, E., et al. (1997). Cloning
formed as previously described (Roberson and Sweatt, 1996). of the SCA7 gene reveals a highly unstable CAG repeat expansion.
Briefly, hippocampal slices (400 m) were maintained in an interface Nat. Genet. 17, 65–70.
chamber and bathed in oxygenated artificial cerebral spinal fluid de Jong, P.T., de Jong, J.G., de Jong-Ten Doeschate, J.M., and
(ACSF, 125 mM NaCl, 2.5 mM KCl, 1.24 mM NaH2PO4, 25 mM Delleman, J.W. (1980). Olivopontocerebellar atrophy with visual dis-
NaHCO3, 10 mM D-glucose, 2 mM CaCl2 and 1 mM MgCl2) (1 ml/ turbances. An ophthalmologic investigation into four generations.
min) at 30C. Extracellular field recordings were made every 20 s Ophthalmology 87, 793–804.
in area CA1 stratum radiatum during stimulation of the Schaffer
de Raad, S., Szczesny, P.J., Munz, K., and Reme, C.E. (1996). Lightcollateral pathway. Stable baseline synaptic transmission was es-
damage in the rat retina: glial fibrillary acidic protein accumulatestablished for 20 min at an intensity of 40%–50% of the maximum
in Mu¨ller cells in correlation with photoreceptor damage. Ophthalmicpopulation excitatory postsynaptic potential (pEPSP) prior to LTP-
Res. 28, 99–107.inducing high-frequency stimulation (HFS). Stimulus intensity of the
Fernandez-Funez, P., Nino-Rosales, M.L., de Gouyon, B., She,HFS was matched to the intensity used in the baseline recordings,
W.-C., Luchak, J.M., Martinez, P., Turiegano, E., Benito, J., Capovilla,and measurements are shown as the average slope of the pEPSP
M., Skinner, P.J., et al. (2000). Identification of genes that modifyfrom six individual traces standardized to baseline recordings. LTP
ataxin-1-induced neurodegeneration. Nature 408, 101–106.was induced by one or three sets of HFS, each set consisting of
two trains of 100 Hz stimulation for 1 s, separated by 20 s (NMDA- Furukawa, T., Morrow, E.M., Li, T., Davis, F.C., and Cepko, C.L.
dependent LTP induction), or a single train of 200 Hz stimulation (1999). Retinopathy and attenuated circadian entrainment in Crx-
for 1 s (NMDA-independent LTP induction). PTP was induced by a deficient mice. Nat. Genet. 23, 466–470.
single 100 Hz HFS train for 1 s following at least 20 min of stable
Garden, G.A., Libby, R.T., Fu, Y.H., Kinoshita, Y., Huang, J., Possin,
baseline recordings in the presence of AP-5. Immediately after the
D.E., Smith, A.C., Martinez, R.A., Fine, G.C., Grote, S.K., et al. (2002).
HFS, pEPSPs were recorded every 3 s for 5 min and are presented
Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous
as the average of four individual traces.
purkinje cell degeneration and displays proteolytic cleavage in
ataxic transgenic mice. J. Neurosci. 22, 4897–4905.
Acknowledgments Goldberg, A.F., and Molday, R.S. (1996). Defective subunit assembly
underlies a digenic form of retinitis pigmentosa linked to mutations
We thank Barbara Antalffy and Zhuo Yang for technical assistance; in peripherin/rds and rom-1. Proc. Natl. Acad. Sci. USA 93, 13726–
Jean-Louis Mandel, Ga¨el Yvert, and Dominique Helmlinger for 1261 13730.
and 1597 antibodies; Monica Holmberg for SCA7 (1-135) antibody;
Gusella, J.F., and MacDonald, M.E. (2000). Molecular genetics: un-
and Vicky Brandt for a critical reading of the manuscript. This work
masking polyglutamine triggers in neurodegenerative disease. Nat.
was supported by the following NIH grants: NS27699 (to H.Y.Z.),
Rev. Neurosci. 1, 109–115.
EY12543 (to S.C.), EY 04446 and EY 02520 (to S.M.W.), and HD24064
Havener, W.H. (1951). Cerebellar-macular abiotrophy. Arch. Opthal-(to the Baylor College of Medicine Mental Retardation Research
mol. 25, 40–43.Center). The Retina Research Foundation (Houston) and the Interna-
tional Retinal Research Foundation also support S.M.W. H.Y.Z is an Hong, D.H., Pawlyk, B.S., Shang, J., Sandberg, M.A., Berson, E.L.,
and Li, T. (2000). A retinitis pigmentosa GTPase regulator (RPGR)-Investigator with the Howard Hughes Medical Institute.
Neuron
400
deficient mouse model for X-linked retinitis pigmentosa (RP3). Proc. Pierce, E.A. (2001). Pathways to photoreceptor cell death in inherited
retinal degenerations. Bioessays 23, 605–618.Natl. Acad. Sci. USA 97, 3649–3654.
Pugh, E.N., Jr., Falsini, B., and Lyubarsky, A.L. (1998). The origin ofHood, D.C., and Birch, D.G. (1994). Understanding changes in the
the major rod- and cone-driven components of the rodent electro-b-wave of the ERG caused by heterogeneous receptor damage.
retinogram, and the effect of age and light-rearing history on theInvest. Ophthalmol. Vis. Sci. 35, 2948–2961.
magnitudes of these components. In Photostasis and Related Top-Humphries, M.M., Rancourt, D., Farrar, G.J., Kenna, P., Hazel, M.,
ics, T.P. Williams and A.B. Thistle, eds. (New York: Plenum), pp.Bush, R.A., Sieving, P.A., Sheils, D.M., McNally, N., Creighton, P.,
93–128.et al. (1997). Retinopathy induced in mice by targeted disruption of
Rattner, A., Smallwood, P.M., Williams, J., Cooke, C., Savchenko, A.,the rhodopsin gene. Nat. Genet. 2, 216–219.
Lyubarsky, A., Pugh, E.N., and Nathans, J. (2001). A photoreceptor-Johansson, J., Forsgren, L., Sandgren, O., Brice, A., Holmgren, G.,
specific cadherin is essential for the structural integrity of the outerand Holmberg, M. (1998). Expanded CAG repeats in Swedish
segment and for photoreceptor survival. Neuron 32, 775–786.spinocerebellar ataxia type 7 (SCA7) patients: effect of CAG repeat
Rich, K.A., Zhan, Y., and Blanks, J.C. (1997). Migration and synapto-length on the clinical manifestation. Hum. Mol. Genet. 7, 171–176.
genesis of cone photoreceptors in the developing mouse retina. J.
Kato, T., Tanaka, F., Yamamoto, M., Yosida, E., Indo, T., Watanabe,
Comp. Neurol. 388, 47–63.
H., Yoshiwara, T., Doyu, M., and Sobue, G. (2000). Sisters homozy-
Roberson, E.D., and Sweatt, J.D. (1996). Transient activation of cy-gous for the spinocerebellar ataxia type 6 (SCA6)/CACNA1A gene
clic AMP-dependent protein kinase during hippocampal long-termassociated with different clinical phenotypes. Clin. Genet. 58, 69–73.
potentiation. J. Biol. Chem. 271, 30436–30441.
Kawakami, H., Maruyama, H., Nakamura, S., Kawaguchi, Y., Kaki-
Ryan, S.J.J., Knox, D.L., Green, W.R., and Konigsmark, B.W. (1975).zuka, A., Doyu, M., and Sobue, G. (1995). Unique features of the
Olivopontocerebellar degeneration. Clinicopathologic correlation ofCAG repeats in Machado-Joseph disease. Nat. Genet. 9, 344–345.
the associated retinopathy. Arch. Ophthalmol. 93, 169–172.
La Spada, A.R., Fu, Y.H., Sopher, B.L., Libby, R.T., Wang, X., Li,
Sato, K., Kashihara, K., Okada, S., Ikeuchi, T., Tsuji, S., Shomori, T.,L.Y., Einum, D.D., Huang, J., Possin, D.E., Smith, A.C., et al. (2001).
Morimoto, K., and Hayabara, T. (1995). Does homozygosity advancePolyglutamine-expanded ataxin-7 antagonizes CRX function and
the onset of dentatorubral-pallidoluysian atrophy? Neurology 45,induces cone-rod dystrophy in a mouse model of SCA7. Neuron 31,
1934–1936.913–927.
Semple-Rowland, S.L., Adamus, G., Cohen, R.J., and Ulshafer, R.J.Lamb, T.D., and Pugh, E.N., Jr. (1992). G-protein cascades: gain
(1991). Expression of glial fibrillary acidic protein by Mu¨ller cells inand kinetics. Trends Neurosci. 15, 291–298.
rd chick retina. Electrophoresis 12, 307–312.
Lang, A.E., Rogaeva, E.A., Tsuda, T., Hutterer, J., and St George-
Skinner, P.J., Koshy, B.T., Cummings, C.J., Klement, I.A., Helin, K.,Hyslop, P. (1994). Homozygous inheritance of the Machado-Joseph
Servadio, A., Zoghbi, H.Y., and Orr, H.T. (1997). Ataxin-1 with andisease gene. Ann. Neurol. 36, 443–447.
expanded glutamine tract alters nuclear matrix-associated struc-
Lin, X., Antalffy, B., Kang, D., Orr, H.T., and Zoghbi, H.Y. (2000). tures. Nature 389, 971–974.
Polyglutamine expansion down-regulates specific neuronal genes
Sobue, G., Doyu, M., Nakao, N., Shimada, N., Mitsuma, T., Maru-
before pathologic changes in SCA1. Nat. Neurosci. 3, 157–163.
yama, H., Kawakami, S., and Nakamura, S. (1996). Homozygosity
Lin, C.H., Tallaksen-Greene, S., Chien, W.M., Cearley, J.A., Jackson, for Machado-Joseph disease gene enhances phenotypic severity.
W.S., Crouse, A.B., Ren, S., Li, X.J., Albin, R.L., and Detloff, P.J. J. Neurol. Neurosurg. Psychiatry 60, 354–356.
(2001). Neurological abnormalities in a knock-in mouse model of Stro¨m, A.L., Jonasson, J., Hart, P., Brannstrom, T., Forsgren, L., and
Huntington’s disease. Hum. Mol. Genet. 10, 137–144. Holmberg, M. (2002). Cloning and expression analysis of the murine
Lindenberg, K.S., Yvert, G., Muller, K., and Landwehrmeyer, G.B. homolog of the spinocerebellar ataxia type 7 (SCA7) gene. Gene
(2000). Expression analysis of ataxin-7 mRNA and protein in human 285, 91–99.
brain: evidence for a widespread distribution and focal protein accu- Sweatt, J.D. (1999). Toward a molecular explanation for long-term
mulation. Brain Pathol. 10, 385–394. potentiation. Learn. Mem. 6, 399–416.
Lyubarsky, A.L., Falsini, B., Pennesi, M.E., Valentini, P., and Pugh, Takiyama, Y., and Tsuji, S. (1995). The characteristics and the gene
E.N., Jr. (1999). UV- and midwave-sensitive cone-driven retinal re- locus of Machado Joseph disease. No To Shinkei 47, 117–129.
sponses of the mouse: a possible phenotype for coexpression of
To, K.W., Adamian, M., Jakobiec, F.A., and Berson, E.L. (1992).cone photopigments. J. Neurosci. 19, 442–455.
Olivopontocerebellar atrophy with retinal degeneration. An electro-
Lyubarsky, A.L., Chen, C., Simon, M.I., and Pugh, E.N., Jr. (2000). retinography and histopathologic investigation. Ophthalmology 100,
Mice lacking G-protein receptor kinase 1 have profoundly slowed 15–23.
recovery of cone-driven retinal responses. J. Neurosci. 20, 2209–
Traboulsi, E.I., Maumenee, I.H., Green, W.R., Freimer, M.L., and2217.
Moser, H. (1988). Olivopontocerebellar atrophy with retinal degener-
Mauger, C., Del-Favero, J., Ceuterick, C., Lubke, U., van Broeckho- ation. A clinical and ocular histopathologic study. Arch. Ophthalmol.
ven, C., and Martin, J. (1999). Identification and localization of 106, 801–806.
ataxin-7 in brain and retina of a patient with cerebellar ataxia type
Usdin, M.T., Shelbourne, P.F., Myers, R.M., and Madison, D.V.
II using anti-peptide antibody. Brain Res. Mol. Brain Res. 74, 35–43.
(1999). Impaired synaptic plasticity in mice carrying the Huntington’s
Morrow, E.M., Furukawa, T., and Cepko, C.L. (1998). Vertebrate disease mutation. Hum. Mol. Genet. 8, 839–846.
photoreceptor cell development and disease. Trends Cell Biol. 9, van de Warrenburg, B.P., Frenken, C.W., Ausems, M.G., Kleefstra,
353–358. T., Sinke, R.J., Knoers, N.V., and Kremer, H.P. (2001). Striking antici-
Nakamura, K., Jeong, S.Y., Uchihara, T., Anno, M., Nagashima, K., pation in spinocerebellar ataxia type 7: the infantile phenotype. J.
Nagashima, T., Ikeda, S., Tsuji, S., and Kanazawa, I. (2001). SCA17, a Neurol. 248, 911–914.
novel autosomal dominant cerebellar ataxia caused by an expanded Watase, K., Weeber, E.J., Xu, B., Antalffy, B., Yuva-Paylor, L., Hashi-
polyglutamine in TATA-binding protein. Hum. Mol. Genet. 10, 1441– moto, K., Kano, M., Atkinson, R., Sun, Y., Armstrong, D.L., et al.
1448. (2002). A long CAG repeat in the mouse Sca1 locus replicates SCA1
Neetens, A., Martin, J.J., Libert, J., and Van den Ende, P. (1990). features and reveals the impact of protein solubility on selective
Autosomal dominant cone dystrophy-cerebellar atrophy (ADCoCA) neurodegeneration. Neuron 34, 905–919.
(modified ADCA Harding II). Neuroophthalmology 10, 261–275. Yoo, S., and Zoghbi, H.Y. (2002). Dominantly inherited spinocerebel-
lar syndromes. In Neuromuscular Disorders of Infancy, Childhood,Pennesi, M.E., Cho, J.H., Yang, Z., Wu, S., Zhang, J., Wu, S.M.,
and Tsai, M.J. (2003). BETA2/NeuroD null mice: a new model for and Adolescence: A Clinician’s Approach, H.R. Jones, D.C. De Vivo,
and B.T. Darras, eds. (Woburn, MA: Butterworth-Heinemann), pp.transcription factor dependent photoreceptor degeneration. J.
Neurosci., in press. 1165–1183.
Pathogenic Effects of Mutant Ataxin-7 in SCA7 Mice
401
Yvert, G., Lindenberg, K.S., Picaud, S., Landwehrmeyer, G.B., Sahel,
J.A., and Mandel, J.-L. (2000). Expanded polyglutamines induce
neurodegeneration and trans-neuronal alterations in cerebellum and
retina of SCA7 transgenic mice. Hum. Mol. Genet. 9, 2491–2506.
Yvert, G., Lindenberg, K.S., Devys, D., Helmlinger, D., Landwehr-
meyer, G.B., and Mandel, J.-L. (2001). SCA7 mouse models show
selective stabilization of mutant ataxin-7 and similar cellular re-
sponses in different neuronal cell types. Hum. Mol. Genet. 10, 1679–
1692.
Zoghbi, H.Y., and Botas, J. (2002). Mouse and fly models of neurode-
generation. Trends Genet. 18, 463–471.
Zoghbi, H.Y., and Orr, H.T. (2000). Glutamine repeats and neurode-
generation. Annu. Rev. Neurosci. 23, 217–247.
Zucker, R.S., and Regehr, W.G. (2002). Short-term synaptic plastic-
ity. Annu. Rev. Physiol. 64, 355–405.
